Quantcast
Last updated on April 16, 2014 at 17:11 EDT

Latest American Society for Radiation Oncology Stories

2010-10-23 01:41:15

The following are highlights of new cancer research being released at the American Society for Radiation Oncology's (ASTRO) 52nd Annual Meeting to be held October 31 through November 4, 2010, in San Diego. For full copies of the abstracts and press releases, contact Nicole Napoli at nicolen@astro.org or Beth Bukata at bethb@astro.org. Studies are embargoed until October 25, 2010, at 1:00 p.m. Eastern time. Adding radiation to hormone therapy for prostate cancer treatment will increase...

2010-10-22 14:17:00

SAN DIEGO, Oct. 22 /PRNewswire-USNewswire/ -- The following are highlights of new cancer research being released at the American Society for Radiation Oncology's (ASTRO) 52nd Annual Meeting to be held October 31 through November 4, 2010, in San Diego. For full copies of the abstracts and press releases, contact Nicole Napoli at nicolen@astro.org or Beth Bukata at bethb@astro.org. Studies are embargoed until October 25, 2010, at 1:00 p.m. Eastern time. Adding radiation to hormone therapy...

2010-08-05 14:05:36

The American Society for Radiation Oncology (ASTRO) has released evidence-based guidelines to define appropriate fractionation of whole breast irradiation (WBI), finding that hypofractionated (HF) WBI is effective for many patients with early-stage breast cancer. These guidelines are published in the International Journal of Radiation Oncology"¢Biology"¢Physics, the official journal of ASTRO. Studies have shown that WBI following breast conserving surgery lowers the risk of tumor...

2010-06-24 09:26:00

Gathering brings clinicians, manufacturers, regulators, hospital administrators, and public interest groups together to discuss new ways of avoiding errors COLLEGE PARK, Md., June 24 /PRNewswire-USNewswire/ -- A meeting in Miami this week will bring together some of the world's leading experts from inside and outside the clinic to discuss safety in radiation therapy -- a critical method for treating cancer. Surgery, radiation therapy and chemotherapy are the three main treatments for...

2010-06-02 21:17:10

PMRT increases 5-year overall survival by almost 50 percent Postmastectomy radiation therapy (PMRT) for some breast cancer patients can reduce their risk of recurrence by almost 30 percent and increase their five-year overall survival by almost 50 percent, according to a study in the June 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO). Surgery and radiation are common methods for treating...

2010-04-28 14:40:22

Finds SBRT to be good alternative to surgery in some lung cancer patients The American Society for Radiation Oncology (ASTRO) has released its Emerging Technology Committee's report evaluating the use of stereotactic body radiotherapy (SBRT) in lung cancer treatment. SBRT is a newer radiation therapy treatment that uses focused radiation beams to target a well-defined tumor and relies on detailed imaging, computerized three-dimensional treatment planning and precise treatment setup to deliver...

2010-03-08 13:28:35

Prostate-specific dietary supplements should not be taken during radiation therapy treatments because they have been shown to increase the radiosensitivity of normal prostate cell lines, leading to normal tissue complications, according to a study in the March issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO). Many prostate cancer patients choose to take nutritional supplements to improve or...

2010-02-05 14:08:23

The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) have released practice guidelines for image guided radiation therapy (IGRT) and stereotactic body radiation therapy (SBRT) in the February issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO. These guidelines were released as educational tools to assist practitioners in providing appropriate, effective and safe medical care for patients. IGRT uses...

2010-01-05 16:35:27

Sexual function in prostate cancer patients receiving external beam radiation therapy (EBRT) decreases within the first two years after treatment but then stabilizes and does not continuously decline as was previously thought, according to a study in the January 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO). Prostate cancer is the most common male cancer other than skin cancer. It can be...

2009-12-02 18:37:39

Prostate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to have a cancer recurrence and cancer-related death, according to a study in the December 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO). PSA levels in a prostate cancer patient are monitored after a patient's...